Peterborough, Canada Clinical Trials

A listing of Peterborough, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 72 clinical trials
None
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiority of lecanemab compared with placebo on the change from baseline in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) at 18 months of treatment in the Core Study. This …

Kawartha Centre - Redefining Healthy Aging
 (0.2 away) Contact site
  • 245 views
  • 05 Jul, 2021
  • +275 other locations
None
Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo

The purpose of this study is to evaluate the duration of response following withdrawal of ruxolitinib cream (Cohort A vehicle group), safety and maintenance of response with continued use of ruxolitinib cream in participants who have completed either Study NCT04052425 or NCT04057573 (parent studies) in which the participants will have …

Skin Centre for Dermatology
 (1.8 away) Contact site
  • 220 views
  • 04 Jul, 2021
  • +83 other locations
None
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

This study is being conducted to evaluate the safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 genotype. This is a double-blind, randomized trial with one dose of ALZ-801 compared to placebo.

Kawartha Centre
 (0.2 away) Contact site
  • 0 views
  • 22 Nov, 2021
  • +85 other locations
None
A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo

The purpose of this study is to evaluate the efficacy and safety of INCB054707 over a 24-week placebo-controlled double-blind treatment period, followed by a 28-week double-blind extension period in participants with nonsegmental vitiligo.

Skin Centre for Dermatology
 (1.8 away) Contact site
  • 16 views
  • 19 Nov, 2021
  • +48 other locations
None
Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)

This study will assess the safety and efficacy of ARQ-154 foam vs vehicle applied once daily for 8 weeks by subjects with scalp and body psoriasis.

Arcutis Biotherapeutics Clinical Site 32
 (1.9 away) Contact site
  • 3 views
  • 14 Nov, 2021
  • +48 other locations
None
A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis

Psoriasis is a chronic disease characterized by marked inflammation and thickening of the skin that results in thick, scaly skin plaques. This study will assess how safe and effective cedirogant (ABBV-157) is compared to placebo in adult participants with moderate to severe psoriasis. Efficacy and safety-related measurements are assessing disease …

phototherapy
systemic therapy
plaque psoriasis
desquamation
SKIN Centre for Dermatology /ID# 238862
 (1.9 away) Contact site
  • 0 views
  • 01 Dec, 2021
  • +44 other locations
None
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation …

arterial disease
percutaneous coronary intervention
acute coronary syndrome
stemi
stroke
1240078 - Kawartha Cardiology Clinical Trials
 (0.6 away) Contact site
  • 1132 views
  • 23 Nov, 2021
  • +3438 other locations
None
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

The purpose of this study is to evaluate the long-term safety and maintenance of efficacy of mirikizumab in participants with moderate-to-severe plaque psoriasis.

plaque psoriasis
mirikizumab
SKiN Centre for Dermatology
 (1.9 away) Contact site
  • 730 views
  • 25 Nov, 2021
  • +367 other locations
None
Long-Term PF-06651600 for the Treatment of Alopecia Areata

This is a global Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescents (12 years and older) who have alopecia areata. Eligible patients from the prior studies B7931005 (NCT02974868) and B7981015 (NCT03732807) will have an opportunity to enroll as …

alopecia totalis
pf-06651600
alopecia
areata alopecia
androgenic alopecia
SKiN Centre for Dermatology
 (1.9 away) Contact site
  • 1703 views
  • 10 Oct, 2021
  • +177 other locations
None
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults without a prior myocardial infarction (MI) or stroke who are at high risk of a cardiovascular event.

infarct
arterial disease
myocardial infarction
diabetes
stroke
Research Site
 (0.6 away) Contact site
  • 542 views
  • 27 Nov, 2021
  • +1350 other locations